SEC Form 4 · accession 0001683168-17-000533
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Miller
Officer — Chief Financial Officer
Period of report
Mar 8, 2017
Accepted (ET)
Mar 9, 2017 · 6:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per shareF1 | Mar 8, 2017 | P | 250 | $6.81 | A | 6,964 | I | See Note |
| Common Stock, $0.0001 par value per shareF1 | Mar 8, 2017 | P | 750 | $6.97 | A | 7,714 | I | See Note |
| Common Stock, $0.0001 par value per share | holding | — | — | — | 15,964 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees.